Harness the Power of HTG's Propietary Transcriptome Panel
Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.
Featured Publication
Overview of the Design and Performance of the HTG Transcriptome Panel
READ PUBLICATION
HTG Molecular News & Events
ESMO CONGRESS 2022
SEPTEMBER 9-13, 2022 | Join us at the European Society for Medical Oncology Congress in Paris, France
- Category:
- Future Events
12th Annual World Clinical Biomarkers and CDx Summit
SEPTEMBER 28-29, 2022 | Join us at the 12th Annual World Clinical Biomarkers and CDx Summit in Boston, MA
- Category:
- Future Events
- Topics:
- CDx
- Clinical Biomarker
- Conference
- HTG
The Festival of Genomics & Biodata 2023
January 25-26 | Come and see us in London at the 2023 Festival of Genomics
- Category:
- Future Events
HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11
TUCSON, Ariz. , Aug. 04, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended…
- Category:
- Press Releases
HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition
TUCSON, Ariz. , July 19, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will host a key opinion leader (KOL) webinar on “ Drug…
- Category:
- Press Releases
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
TUCSON, Ariz. , July 18, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced it has entered into an amendment of its June 24, 2020 Loan and…
- Category:
- Press Releases
Resources
Find product information, specifications and gene lists here.
Support
Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or panels.
Log in to your accountPage last updated January 31, 2022
Ready to get started?
HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.